INTRODUCTION
Chronic obstructive pulmonary disease (COPD) is characterized by not reversible airflow limitation. 1 This disease affects more than 200 million people and is a leading cause of morbidity and mortality worldwide. 2 Cigarette smoke (CS) exposure is the most important risk factor for COPD. 3 Exposure to CS induces a strong burden of reactive oxygen species in the lung leading to imbalance between oxidants and antioxidants. 4 An important part of this oxidative stress is related to lipid peroxidation, a phenomenon that can be mimicked by administration of cumen hydroperoxide (CHP). 5 CS-induced oxidative stress is involved in COPD development through its role in airway inflammation. Long-term exposure to CS leads to the recruitment of macrophages, neutrophils and CD8 þ T cells, 6 which amplify the oxidative stress in the lungs. 7 Previous findings have provided evidences that cells of the innate immune system, including NK cells, are sufficient to induce inflammation and emphysema after chronic CS exposure. 8 Invariant natural killer T (iNKT) cells comprise a subset of lymphocytes that express features of classical NK and T cells, including restricted TCR consisting of an invariant VaJa-chain (Va24-Ja18 in humans and Va14-Ja18 in mice) combined with a more polyclonal Vb-chain (Vb11 in humans, Vb8.2, 7, and 2 in mice). iNKT cells recognize (glyco)lipid Ag presented by the non polymorphic MHC class I-like protein, CD1d, widely expressed by macrophages, dendritic cells (DC), airway epithelial cells (AECs) and B cells. 9 Recognition of CD1d-presented lipids by iNKT cells is highly conserved among different mammalian species, suggesting that iNKT cells have a pivotal role in immunity. 9, 10 Activation of iNKT cells results in an innate-like immune response characterized by an important production of cytokines (interferon (IFN)-g, interleukin (IL)-4, and IL-17), 9, 11 and cytotoxic proteins (granzyme B and perforin). 12, 13 This rapid response endows iNKT cells with the capacity to critically amplify innate and adaptive immunity. Several studies have defined the impact of iNKT-cell activation on the development of diseases, including infectious diseases and asthma.
Others and we have shown that iNKT are involved in the control of airway inflammation and hyperreactivity in mice, in models of allergic reaction, 17, 18 and after exposure to oxidant pollutants such as ozone. 19 Kim et al. 20 also showed that iNKT cells are implicated in an experimental model of chronic lung disease induced by Sendai virus infection, with pathology that resembles asthma and COPD. Of interest is the recent observation that patients developing COPD have an increased number of iNKT cells in the blood and the lungs. [20] [21] [22] [23] In the current study, we investigated the potential role of iNKT cells in a model of chronic exposure to CS mimicking COPD symptoms, and in an acute model of lipid peroxidation using CHP as the trigger. We demonstrated that exposure of mice to CS and to CHP-induced changes in lung functions that requires the presence of iNKT cells. These effects were dependant on oxidative stress as addition of the anti-oxidant N-acetylcystein (NAC) prevents the activation of iNKT cells and the deleterious effects of CS. We showed that CS-induced oxidative stress in AEC and DC was responsible for iNKT-cell activation both in humans and mice. Targeting iNKT cells may represent an effective therapeutic approach to control COPD in humans.
RESULTS

Activated NKT cells in peripheral blood of COPD patients
We first aimed to determine the frequency of (i)NKT cells in COPD patients (Supplementary Table 2 Figure 1a) . Increased percentages of circulating DC, and higher expression of CD86 on DC were observed in COPD patients (Figure 1b) . Pulmonary inflammation was confirmed by higher levels of CXCL-8 and TNF-a in their sputum, and increased production of IL-22 and IFN-g by PBMC (Supplementary Figure 2 online ). These data suggest that (i)NKT cells could be involved in COPD pathology.
CS exposure triggers the accumulation and the activation of iNKT cells in the lungs
Repeated exposure of C57BL/6 mice to CS induced an inflammatory lung reaction, mimicking COPD, as previously described. 8 This was characterized by neutrophil, NK cell and macrophage recruitment ( þ 30-50%) and/or activation after chronic exposure to CS, compared with mice exposed to ambient air (Figure 3c, Figure 5a ). The frequency and number of pulmonary iNKT cells was enhanced after CS exposure ( Figure 2a) ; these parameters then returned to basal levels at week 2 post-exposure to again increase at weeks 4, 8, and 12. An increased expression of the activation marker CD69 on iNKT cells persisted all along the experiment (Figure 2b and not shown). Analysis of CD5 þ NK1.1 þ cells confirmed these data (Supplementary Figure 3A and B, and not shown). In contrast, the proportion, the number, and the activation status of iNKT cells remained unchanged in the spleen of CS-exposed mice (Supplementary Figure 3C -E). PMA/ionomycin stimulation of lung cells resulted in a higher frequency of IL-17 þ and IFNg þ iNKT cells at 1 week post CS exposure ( Figure 2c ) and later (not shown). Stimulation of pulmonary cells from CS-exposed mice with the prototypical iNKT-cell activator aGalCer resulted in a higher production of IL-17 at 1 and 12 weeks post-CS exposure. In contrast, a significant enhancement of IFN-g production was observed only at 12 weeks post-exposure (Figure 2d) . No difference in IL-4 levels was observed (not shown). Collectively, CS exposure leads to an increased recruitment or a local expansion of activated iNKT cells in the lungs.
iNKT cells are required in CS-induced airway inflammation and lung alterations Exposure of WT mice to CS resulted in a severe increase in lung resistance ( Figure 3a) . Remarkably, both CS-exposed Cd1d À / À mice, which lack iNKT and variant NKT cells, as well as Ja18 À / À mice, which are only devoid of iNKT cells, showed no changes in their lung resistance (Figure 3a) , dynamic compliance and 
HLA-DR
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Histological analysis revealed a decreased pathology in (i)NKT cell-deficient animals ( Figure 3b) . WT mice exposed to CS, but not Cd1d À / À and Ja18 À / À mice, had enlarged alveolar spaces (emphysema) and airway remodeling associated to a mild inflammatory infiltrate. Measurements of airspace cord length were also performed to evaluate lung injuries. This was significantly increased in CS-exposed WT mice (49.7 mm±2.1 compared with 32.1 mm±1.1 in air-exposed mice, Po0.001), but not in CS-exposed Ja18 À / À mice (40.6 mm ± 1.7). There is no statistical difference in airspace cord length between air-and CS-exposed Cd1d À / À as well as Ja18 À / À mice (P ¼ NS). CS exposure resulted in the infiltration of neutrophils and NK cells in the BAL (not shown) and in the lungs of WT mice (Figure 3c) , as previously described. 24 No significant recruitment of neutrophils and NK cells was observed after CS exposure in Cd1d À / À and Ja18 À / À mice ( Figure 3c and not shown). CS exposure induced higher levels of Il-17 and Il-1b mRNA, but this increased expression was not observed in Ja18
À / À mice ( Figure 3d and Supplementary Figure 4C ). Pulmonary Ifn-g expression was not modulated in NKT-deficient mice exposed to CS (not shown). mRNA levels of Mmp12, a key mediator in smoke induced emphysema, 25 were markedly induced by CS exposure in WT animals, but not in Ja18 À / À mice ( Figure 3e ). Altogether, this indicated that CS-induced alterations of lung function, inflammation, and emphysema strongly relied on iNKT cells. To confirm the role of iNKT cells in lung damage induced by oxidant stress, we developed a more acute model based on CHP treatment, a compound that specifically triggers lipid peroxidation. 5 Exposure to CHP led to an enhanced frequency and number of pulmonary iNKT cells (Figure 4a upregulation of CD40 and MHC class II (I-A) on AM and DC, a phenomenon also observed in Ja18 À / À mice ( Figure 5b and Supplementary Figure 5C ). CD1d expression was enhanced on AM and DC, although not significantly for the latter (Figure 5c ).
To investigate the potential ability of AM and DC to trigger iNKT-cell activation, we sorted AM and the two predominant lung DC subsets, namely CD11b þ CD103 À DC (referred to as CD11b þ ) and CD11b À CD103 þ DC (here referred to as CD103 þ ) (Supplementary Figure 1) at 2 and 10 weeks post CS exposure. Of interest, cell-sorted CD11b þ DC, but not CD103 þ DC, nor AM, expressed higher levels of Il-12p40 and Cd1d transcripts (Figure 5d) , two crucial factors for iNKTcell activation. 14 The expression of Il-23p19 was unchanged in these cells (not shown), whereas it was increased in the total lungs (Supplementary Figure 6A) . The transcript level of Ugcg and to a lesser extend St3gal5, both enzymes initiating biosynthesis of glycolipids activators of iNKT cells, 26 was enhanced in CD11b þ DC, but not in CD103 þ DC or AM (Figure 5d ). St3gal5 expression was increased in the lungs of CS-exposed animals (Supplementary Figure 6B) .
To assess the possibility that CS directly drives DC to stimulate iNKT cells, BM-DC were exposed to CS extracts (CSE) in vitro and next cocultured with sorted primary iNKT cells. Compared with unstimulated BM-DC, CSE-treated BM-DC triggered IL-17 and IFN-g production by iNKT cells (Figure 5e) although at a lower level compared with a-GalCer (data not shown). Among structural pulmonary cells, AEC are numerous and are directly in contact with aeropollutants. We therefore investigated the possibility that AEC might be important in iNKT-cell activation. Primary mouse AEC exposed to a-GalCer induced in a CD1d-dependant manner the production of IL-2 by DN32 iNKT hybridoma and mainly IL-4 by sorted splenic iNKT cells (Supplementary Figure 7) . In addition, mouse AEC exposed to CSE had the potential to induce IFN-g, but not IL-17, production by iNKT cells (Figure 5f and not shown). These data showed that CS exposure in mice primed DC and AEC, to activate iNKT cells.
Human CSE-stressed DC and AEC stimulate iNKT cells
We next aimed to validate these results using human cells. Both DC and AEC were exposed to CS and cocultured with iNKTcell lines. CSE-treated DC induced IFN-g and IL-17 release by iNKT cells (Figure 6a right) . In contrast, CSE-treated AEC only induced IFN-g production (Figure 6a left) .
Exposure to CSE enhanced mRNA expression of UGCG and ST3GAL5, and of the oxidation markers, NADPH deshydrogenase Quinone-1 (NQO-1) and heme-Oxygenase-1 (HO-1) (Figure 6b and Supplementary Figure 8) with a different time course in both DC and AEC. To test the implication of oxidative stress in iNKT-cell activation, APC were pretreated with the anti-oxidant NAC. NAC-pretreatment of CSEexposed DC and AEC strongly diminished iNKT-cell activation (Figure 6c) . This was associated with a strong decrease in levels of HO-1 and UGCG in APC (Figure 6d and Supplementary Figure 8) . These data show that human DC and AEC exposed to CS-induced oxidative stress trigger iNKT-cell activation. 
NAC prevents CS-induced decline in lung functions and iNKT-cell activation
To establish a link between oxidative stress, iNKT-cell activation and decreased lung functions, mice were treated with NAC during the course of chronic CS exposure. NAC treatment limited the alteration of lung function (Figure 7a and Supplementary Figure 8) . CS-exposed animals treated with NAC displayed less airway remodeling, as depicted by a reduced alveolar enlargement (Figure 7b) . NAC treatment significantly reduced the airspace cord length (from 49.7 mm ± 2.1 in CS-exposed mice to 37.2 mm ± 1.2 in CS-exposed NAC-treated mice, Po0.001). This was associated with a reduced expression of Mmp12 in the lung (data not shown). Administration of NAC reduced the weight loss due to CS exposure (Figure 7c) . NAC treatment also prevented the accumulation and the increased expression of CD69 on pulmonary iNKT cells (Figure 7d) . In response to aGalCer, the level of IL-17 in supernatants from lung cells was reduced by 75% in the CS-exposed group receiving NAC, whereas no changes were observed for IFN À g and IL-4 ( Figure 7e ). Of note, upon CD3 Ab restimulation, NAC decreased both IFN-g and IL-17 release in lung cells (Figure 7e) . These data showed that the anti-oxidant NAC prevents the mobilization and the activation of iNKT cells in CS-exposed mice, an effect that is associated with improved lung function and decreased pathogenesis.
DISCUSSION
Oxidative stress induced by CS is part of the mainstay of COPD physiopathology. This study for the first time demonstrates that iNKT cells are detrimental in experimental COPD, a phenomenon that can be reversed by abrogating oxidative stress in vivo. We also report that lung damage induced by acute exposure to CHP, another oxidative stress inducer, is dependent on iNKT cells. Finally, we report that DC and AEC are important sensors of oxidative stress mediated by CS and that downstream pathways triggered in these cells lead to iNKT-cell activation.
CS contains a myriad of oxidant compounds inducing the production of deleterious reactive oxygen species causing airway inflammation and loss of lung functions. 7, 27, 28 Our COPD model showed an accumulation of iNKT cells in the lungs as early as 1 week post CS exposure. These data are in line with recent studies showing the presence of iNKT cells in the BAL and induced sputum of COPD patients and in blood as shown in the present study. [20] [21] [22] [23] In contrast, Chi et al. 29 and Vijayanand et al. 30 showed that the frequencies of peripheral blood and alveolar CD3 þ 6B11 þ iNKT cells are significantly lower in patients with stable COPD, a finding that might be explained by the less stringent method used to identify NKT cells. 29, 30 The present study highlight the need for a more complete assessment of the innate immune response. To establish a role for NKT cells in COPD, we analyzed NKT cells in the mouse model in combination with human patients. As reported here, iNKT cells displayed an activated phenotype (CD69), both in the blood of COPD patients and during the course of chronic exposure to CS in mice. Furthermore, whenever the time point, iNKT cells from CS-exposed mice produced enhanced levels of cytokines (mainly IL-17) upon stimulation. These results collectively indicate that iNKT cells are recruited, or locally expand, in the lungs and express an activated phenotype (Th17 bias) early during COPD. The potential role of iNKT cells in COPD was next investigated. The absence of iNKT cells (Cd1d À / À and Ja18 À / À mice) abolished most of the features of COPD pathogenesis. The absence of iNKT cells reduced IL-17 production and neutrophil recruitment, the latter being important in the physiopathology of COPD. 31, 32 In parallel, iNKT-cell-deficient animals were protected against lung damage caused by acute CHP exposure, a phenotype restored by adoptive transfer of IL-17 competent iNKT cells. As the lack of iNKT cells only reduced IL-17 in the lungs of COPD mice and neutralizing anti-IL-17 antibodies inhibit the development of COPD, 32 iNKT-cell-derived IL-17, rather than IFN-g, might be instrumental in experimental COPD. We hypothesize that iNKT-cell-derived IL-17 may participate in the recruitment of neutrophils and in the generation of deleterious proteases, including MMP12. Moreover, iNKT cells act as upstream activators of NK cells, other innate cells recently described to have part in COPD. 33 Pulmonary NKT cells have also an essential role in mediating hypoxic acute lung injury. 34 Our previous findings have revealed the deleterious role of iNKT cells in lung functions after ozone exposure, another oxidant, 19 a phenomenon due to Th2-type cytokine production, whereas during COPD (and after CHP treatment, not shown) iNKT cells produced IFN-g and IL-17. We postulate that, according to the type of oxidative stress, different subpopulations and/or pathways can be selected and/or induced in iNKT cells to impair lung functions. A better understanding of the mechanisms by which iNKT cells exert their detrimental effects during COPD is required in the future.
We next sought to decipher the mechanisms of CSdependent activation of iNKT cells. iNKT cells can be stimulated by the mobilization of their TCR and/or by cytokines produced by stressed APC, particularly IL-1b, IL-12, and IL-23.
9,26 Analysis of lung APC subsets from COPD mice indicated that CD11b þ DC strongly matured and expressed markers associated with iNKT-cell activation, including CD1d, IL-1b, and IL-12. Modulation of expression of some glycosyltransferases involved in lipid metabolism in APC is associated with iNKT-cell activation through the presentation of self glycolipids by CD1d. 26, 35, 36 Of interest, the mRNA level of Ugcg, a key enzyme implicated in the generation of endogenous iNKT-cell ligands, was strongly induced in CD11b þ DC during COPD. Importantly, the capacity of CSEexposed DCs to activate iNKT cells was confirmed in vitro, both in the mouse and human systems. While DC are critical activators of iNKT cells, other lung cells such as AEC can express CD1d, 37 although their potential capacity to activate iNKT cells has not yet been examined. We herein showed that both mouse and human AEC sense CSE to trigger iNKT-cell activation. Although DC induced both IFN-g and IL-17 release, CSE-treated AEC only induced IFN-g production. The mechanisms responsible for iNKT-cell activation in response to CSE-exposed sentinel cells are still unknown and worth of future investigations. Our preliminary data using transwells and neutralizing anti-CD1d Abs suggest a major role for both membrane-bound molecules and a complementary participation of soluble factors in iNKT-cell activation. The differential expression of activating factors by CSE-stressed DC vs. AEC might explain the different profile of cytokines released by iNKT cells. Whatever the mechanisms, our data clearly show a direct link between oxidative stress and iNKT-cell stimulation, as NAC treatment ablated the capacity of CSE-treated DC and AEC to activate iNKT cells. As NF-kB activation is a hallmark of CS-induced oxidative stress in APC, 38 it is possible that NFkB-mediated expression of cytokines, CD1d, and/or glycosyltransferases is involved in iNKT-cell activation.
In vivo preventive NAC treatment reversed COPD symptoms. This protective effect was associated with a reduced accumulation and activation of iNKT cells, demonstrating the intricate between oxidative stress, iNKT cells, and COPD. These data might explain some of the beneficial effects of antioxidant treatment in COPD patients. 28 Indeed, NAC affects different signaling pathways, such as NF-kB and MAPK in APC, 39 that could in turn alter iNKT-cell cytokine production, and lead to decrease COPD symptoms, Altogether, our data identified of a new pathogenic mechanism leading to COPD. Elucidating the mechanisms by which oxidative stress activates iNKT cells will be important for the understanding of COPD physiopathology. Direct targeting of APC may provide a potent therapeutic strategy for specifically dampening iNKT-cell activation and controlling lung damage due to COPD.
METHODS
Patients with COPD. Peripheral blood and induced or spontaneous sputum were collected in stable COPD patients (n ¼ 28) and in non smoker healthy controls (n ¼ 7) (CPP 2008-A00690-55) in order to evaluate the phenotype of iNKT-cell and DC as well as cytokine concentrations.
CS exposure. Mice were exposed to CS generated from 5 cigarettes per day, 5 days a week, and up to 12 weeks (Emka, Scireq, Montreal, QC, Canada). The negative-control group was exposed to ambient air. NAC (Sigma-Aldrich, Saint Quentin Fallavier, France) was administrated in the drinking water (300 ng per mouse day), from the beginning of the CS exposure till the day of killing.
Cumen hydroperoxide exposure. Mice were intranasally administered either with 50 ml PBS or 75 mg per 50 ml cumen hydroperoxyde (CHP; Sigma-Aldrich) on days 0, 2, and 4. Mice were killed on day 5 to assess their lung function and inflammation. In adoptive transfer experiments, sorted WT iNKT cells were injected intravenously into Ja18 À / À mice 1 day before the first exposure to CHP.
Measurement of lung function. Lung function was assessed by invasive measurement, as previously described. 40 Aerosolized methacholine (Sigma, Saint Quentin Fallavier, France) was administered in increasing concentrations (from 2.5 to 160 mg ml À 1 of methacholine). We computed airway resistance, dynamic compliance, and lung elastance by fitting flow, volume, and pressure to an equation of motion (Flexivent System, Scireq).
NKT purification, expansion and adoptive transfer in mice. iNKT cells were sorted using a FACSAria (BD Biosciences, Le Pont de Claix, France), from the livers of naive animals, on the basis of PBS57-loaded CD1d tetramer and TCRb staining. Freshly sorted iNKT cells were expanded ex vivo and maintained in culture for 1 month in RPMI 1640 with 10% FCS (Invitrogen, Paisley, UK) containing 30 ng ml À 1 IL-15 (Peprotech, Neuilly Sur Seine, France). For adoptive transfer experiments, Ja18
À / À recipient mice were inoculated intravenously either with 1 Â 10 6 purified WT or Il-17 À / À iNKT cells or with the same volume of medium alone 24 h before exposure to CHP. iNKT-cell purity after sorting was 498%.
Pulmonary APC cell sorting. Pulmonary APC were sorted using a FACSAria on the basis of F4/80, CD11c and CD11b expression. AM CD11b À and CD11b þ DC were sorted. Cell purity after sorting was 498%. Post-sort analysis was performed to evaluate the expression of CD103 on DC subsets. As expected, CD11b
À DC subset was CD103 þ (97% purity) and CD11b þ DC subset was CD103 À (98% purity) (Supplementary Figure 1) . Table 1 ). Results were expressed as mean ± s.e.m. of the relative gene expression calculated for each experiment in folds (2 À DDCt ) using b-actin as a reference, and compared with controls (air).
Statistical analysis. Results are expressed as the mean±s.e.m. The statistical significance of differences between experimental groups was calculated by a one-way analysis of variance with a Bonferroni post test or an unpaired Student t-test (GraphPad, San Diego, CA). The possibility to use these parametric tests was assessed by checking if the population is Gaussian and the variance is equal (Bartlett's test). Results with a P-value o0.05 were considered significant. SUPPLEMENTARY MATERIAL is linked to the online version of the paper at http://www.nature.com/mi
